Support for developing drugs and vaccines for emerging infections
Official title: Core 3: Biocontainment Research Support Services Core
Funded at Duke University · NIH-10910128 · Data updated 2026-11-12
This study is working to improve how we develop new medicines and vaccines for infections by making better testing methods and understanding how our immune system responds, which could lead to better treatments for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project start | August 18, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $957,509 |
| NIH project number | 5UC7AI180254-02 |
| Project ID | NIH-10910128 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit include individuals affected by emerging infectious diseases, such as COVID-19 or other viral infections.
✕Less likely to help
Patients with non-infectious diseases or those not affected by the targeted viral infections may not receive any benefit from this research.
What this research studies
This research focuses on enhancing the capabilities of the Duke Regional Biocontainment Laboratory to support the development of drugs, diagnostics, and vaccines for emerging and re-emerging infections. It aims to refine small animal models for testing and improve virology programs by establishing direct workflows from clinical laboratories. Additionally, the project will broaden immunological assays to monitor immune responses to various pathogens. Patients may benefit indirectly through advancements in treatments and vaccines for infectious diseases.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective treatments and vaccines for serious infectious diseases.
How similar studies have gone: Previous research has shown success in developing treatments and vaccines for infectious diseases using similar biocontainment and animal model approaches.
Where this research is happening
-
Duke University
Durham, United States Active
Researchers
- Principal investigator: Duckett, Colin S. — Duke University
- Study coordinator: Duckett, Colin S.
Related research
Other NIH-funded projects on the same topics.
-
Investigating genetic factors in Lewy body diseases
This study is looking at how changes in a specific gene might play a role in conditions like Parkinson's disease and dementia, so that people can better understand how their genetics affect their health and possibly find more tailored treatments.
-
Targeting the PAX3-FOXO1 protein in a deadly childhood cancer
This study is looking at a specific protein that helps a tough childhood cancer called alveolar rhabdomyosarcoma, with the goal of finding new ways to treat kids who have this illness.
-
Improving population health by studying reproduction and development
This study is looking at how different things in our environment can impact pregnancy and the health of babies, and it’s for people who are planning to have children or are already parents, as it aims to help improve understanding and outcomes for everyone involved.
-
Modeling axon degeneration in C. elegans to help ALS patients
Researchers are using a tiny worm model to uncover how axons break down, which could point to new ways to help people with ALS and related nerve diseases.
-
Induced Suppression of Platelet Activity in Aneurysmal SAH Management
A new approach tests whether carefully reducing platelet activity can improve outcomes after aneurysmal subarachnoid hemorrhage.
-
AI-enhanced virtual reality tool to support remote emergency brain surgery training in Tanzania
A new AI-powered virtual reality tool helps non-experts in low-resource areas get real-time remote guidance for emergency traumatic brain injury surgery.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.